1-2 of 2
Dow-Chung Chi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer

Michael Brave, Chana Weinstock, Jamie R. Brewer, Dow-Chung Chi, Daniel L. Suzman, Joyce Cheng, Lijun Zhang, Rajeshwari Sridhara, Amna Ibrahim, Paul G. Kluetz, Richard Pazdur, Julia A. Beaver
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4717–4722.
https://doi.org/10.1158/1078-0432.CCR-19-3835
Published: 15 September 2020
View article titled, An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer
Open the PDF for An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen

Amy Barone, Dow-Chung Chi, Marc R. Theoret, Huanyu Chen, Kun He, Dubravka Kufrin, Whitney S. Helms, Sriram Subramaniam, Hong Zhao, Anuja Patel, Kirsten B. Goldberg, Patricia Keegan, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7448–7453.
https://doi.org/10.1158/1078-0432.CCR-17-0898
Published: 14 December 2017
View article titled, FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Open the PDF for FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen in another window